EU Must Have Courage To Take The Sensible Decision On IVDR Deadline, Says German Industry
Executive Summary
13 months out from EU IVDR implementation, German diagnostics manufacturers are warning of chaos and disrupted patient care. Meanwhile, COVID’s effects on routine IVD business are clear to see.
You may also be interested in...
German COVID-19 Positive Rate Up To 8%, But Testing Capacity Is At Limits
Enthusiasm over German industry’s role in the coronavirus vaccine breakthrough should not detract from the focus on the national testing strategy, say the COVID-19 PCR testing labs.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.